Abpro Holdings (ABPO) Assets Average (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Assets Average came in at $4.0 million in Q1 2026, up 6.3% YoY from $3.7 million in Q1 2025, and up 186.62% on a QoQ basis from $1.4 million in Q4 2025.
Abpro Holdings (ABPO) Assets Average (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Assets Average data on file, last reported at $4.0 million in Q1 2026.
- Quarterly Assets Average rose 6.3% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 6.3% YoY) and the FY2025 annual result came in at $2.9 million, down 28.59% from the prior year.
- Assets Average climbed to $4.0 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $312.1 million in Q1 2023 to a low of $1.4 million in Q4 2025.
- A 5-year average of $98.0 million and a median of $7.9 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average jumped 103.15% — and 2024, when it tumbled 98.26%.
- Tracing ABPO's Assets Average over 5 years: stood at $309.4 million in 2022, then slumped by 93.39% to $20.4 million in 2023, then sank by 69.37% to $6.3 million in 2024, then slumped by 77.91% to $1.4 million in 2025, then soared by 186.62% to $4.0 million in 2026.
- The last three Assets Average figures came in at $4.0 million (Q1 2026), $1.4 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | 6.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 7.88 Mn |
| Jun 30, 2024 | 7.72 Mn |
| Mar 31, 2024 | 5.44 Mn |
| Dec 31, 2023 | 20.44 Mn |
| Sep 30, 2023 | 37.98 Mn |
| Jun 30, 2023 | 176.05 Mn |
| Mar 31, 2023 | 312.10 Mn |
| Dec 31, 2022 | 309.39 Mn |
| Sep 30, 2022 | 307.60 Mn |
| Jun 30, 2022 | 306.94 Mn |
| Mar 31, 2022 | 153.63 Mn |